Meharry Medical College is a historically black medical school affiliated with the United Methodist Church and located in Nashville, Tennessee. Founded in 1876 as the Medical Department of Central Tennessee College, it was the first medical school for African Americans in the South.

During the past decade, Meharry Medical College conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 57 clinical trials were completed, i.e. on average, 111.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 29 clinical trials were completed. i.e. 207.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meharry Medical College" #1 sponsor was "National Cancer Institute (NCI)" with 31 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Vanderbilt-Ingram Cancer Center" with 13 trials sponsored and "Meharry Medical College" with 13 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meharry Medical College" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Canadian Cancer Trials Group" with 5 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Meharry Medical College" are "Breast Cancer" (16 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Lung Cancer" (8 trials), "Stage IIIA Breast Cancer" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Meharry Medical College" in a lesser frequency.

Most popular intervention types in "Meharry Medical College" are "Drug" (97 trials), "Other" (69 trials), "Biological" (35 trials), "Procedure" (24 trials) and "Behavioral" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (38 trials), "Quality-of-Life Assessment" (20 trials), "Placebo" (14 trials), "Carboplatin" (12 trials) and "Paclitaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Meharry Medical College" are 98 trials for "All" genders, 37 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 53 active trials in "Meharry Medical College". 1 are not yet recruiting, 12 are recruiting, 39 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Meharry Medical College, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Meharry Medical College, 3 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 22 trials that are defined as “Not Applicable".